Addiction, eating disorders, and self-harm.These are not merely issues of disordered lifestyle habits or personal preferences ...

Excessive Daytime Sleepiness in Narcolepsy and OSA: ...

U.S. cancer survivors are significantly more likely to take medications for depression and anxiety compared with noncancer survivors, according to a study published online Aug. 19 in JAMA Network Open ...

BUOY-1 builds on successful Phase 1 and Phase 2a data with GlyphAllo – a novel oral prodrug of allopregnanolone and a potential first-in-class treatment for MDD Allopregnanolone has demonstrated rapid ...

BOSTON--(BUSINESS WIRE)--PureTech Health plc (Nasdaq: PRTC, LSE: PRTC) ("PureTech"), a clinical-stage biotherapeutics company, noted that its Founded Entity, Seaport Therapeutics, (“Seaport”) a ...

BOSTON, July 8, 2025 /PRNewswire/ -- Sensorium Therapeutics, Inc. (Sensorium), a neuroscience therapeutics company inspired by nature and guided by human biology to transform mental health treatment, ...

Though the prevalence of sedative and anxiolytic use disorder diagnoses rose over the last 2 decades, they remain less common than other substance use disorders. The prevalence of sedative, hypnotic, ...

More teens and young adults appear to be developing addiction or dependence on drugs that help them sleep, calm down, and manage anxiety. “Teens and young adults come in with stories that are eerily ...

FRIDAY, Jan. 24, 2025 (HealthDay News) -- Diagnoses of sedative, hypnotic, or anxiolytic use disorders (SHA-UD) increased threefold to fivefold between 2001 and 2019 for adolescent and young adult U.S ...

The prevalence of diagnosed disorders from recurrent use of sedative, hypnotic and antianxiety medications in adolescents and young adults has increased sharply since 2001, according to Rutgers Health ...

The trend warrants attention, given treatment difficulties and the association with other substance use issues, says lead author of Rutgers Health study The prevalence of diagnosed disorders from ...